GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Developments PLC (AQSE:ANA) » Definitions » EV-to-EBIT

Ananda Developments (AQSE:ANA) EV-to-EBIT : -5.42 (As of May. 16, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Ananda Developments EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ananda Developments's Enterprise Value is £9.04 Mil. Ananda Developments's EBIT for the trailing twelve months (TTM) ended in Jul. 2023 was £-1.67 Mil. Therefore, Ananda Developments's EV-to-EBIT for today is -5.42.

The historical rank and industry rank for Ananda Developments's EV-to-EBIT or its related term are showing as below:

AQSE:ANA' s EV-to-EBIT Range Over the Past 10 Years
Min: -8.48   Med: 0   Max: 0
Current: -5.42

AQSE:ANA's EV-to-EBIT is ranked worse than
100% of 667 companies
in the Drug Manufacturers industry
Industry Median: 17.74 vs AQSE:ANA: -5.42

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Ananda Developments's Enterprise Value for the quarter that ended in Jul. 2023 was £14.36 Mil. Ananda Developments's EBIT for the trailing twelve months (TTM) ended in Jul. 2023 was £-1.67 Mil. Ananda Developments's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jul. 2023 was -11.61%.


Ananda Developments EV-to-EBIT Historical Data

The historical data trend for Ananda Developments's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Developments EV-to-EBIT Chart

Ananda Developments Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
EV-to-EBIT
-2.48 -2.57 -2.04 -8.14 -9.04

Ananda Developments Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - -8.14 - -9.04 -

Competitive Comparison of Ananda Developments's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Ananda Developments's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ananda Developments's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ananda Developments's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ananda Developments's EV-to-EBIT falls into.



Ananda Developments EV-to-EBIT Calculation

Ananda Developments's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=9.041/-1.667
=-5.42

Ananda Developments's current Enterprise Value is £9.04 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ananda Developments's EBIT for the trailing twelve months (TTM) ended in Jul. 2023 was £-1.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ananda Developments  (AQSE:ANA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Ananda Developments's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jul. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jul. 2023 ) =EBIT / Enterprise Value (Q: Jul. 2023 )
=-1.667/14.35725
=-11.61 %

Ananda Developments's Enterprise Value for the quarter that ended in Jul. 2023 was £14.36 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ananda Developments's EBIT for the trailing twelve months (TTM) ended in Jul. 2023 was £-1.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ananda Developments EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Ananda Developments's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Ananda Developments (AQSE:ANA) Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Developments PLC provides investment to healthcare market for the companies that develop medicinal or therapeutic cannabis derivatives, or related products including nutraceuticals, dietary supplements, and cosmetic products which contain Cannabis or hemp derived cannabinoids.

Ananda Developments (AQSE:ANA) Headlines

No Headlines